VACCINEX INC
For the period ended Dec 31, 2023. Filed Apr 2, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 2, 2024
VCNX$1.41-61.4%Stored close · as of Dec 17, 2024
What changed in Risk Factors?
Read the current filingComparison unavailable
We do not have an earlier reporting period of the same form for this issuer. A report from another company or an amendment cannot stand in for it.
Unavailable is not the same as unchanged.